Pharmaceutical News

RSS

Breakthrough therapies for blood cancers may provide reasonable value for money spent

Amid the growing debate about the high price of powerful new drugs in the United States, a recent analysis suggests that breakthrough therapies for blood cancers may, in many cases and with some important caveats, provide reasonable value for money spent.

6 Feb 2015

Breakthrough blood cancer therapies may provide reasonable value for money spent

6 Feb 2015

MIT engineers discover way to grow liver-like cells to test potential malaria drugs

In 2008, the World Health Organization announced a global effort to eradicate malaria, which kills about 800,000 people every year. As part of that goal, scientists are trying to develop new drugs that target the malaria parasite during the stage when it infects the human liver, which is crucial because some strains of malaria can lie dormant in the liver for several years before flaring up.

6 Feb 2015

New report explores measures to address shortages of lifesaving medicines

As shortages of lifesaving medicines, including antibiotics, chemotherapy, and cardiovascular drugs continue to plague the United States, a group of health care organizations released a report exploring measures that should be considered to address this ongoing issue. The report summarizes manufacturing, regulatory, and economic issues related to drug shortages, as well as potential solutions that were considered at a 2014 Summit attended by 22 stakeholder groups, including health care professionals and other non-profit organizations, industry, public interest, and government agencies.

6 Feb 2015

G1 Therapeutics receives $33 million in Series B funding to develop effective treatments for cancer

An RTP-based pharmaceutical company with roots at the University of North Carolina at Chapel Hill has received $33 million in Series B venture capital funding to develop more effective and less toxic methods to treat patients with cancer.

6 Feb 2015

Isis receives $10 million from Biogen Idec to begin IND-supporting studies of ISIS-BIIB4 Rx

Isis Pharmaceuticals, Inc. announced today that it has earned a $10 million milestone payment from Biogen Idec for initiating the investigational new drug (IND)-supporting studies of ISIS-BIIB4 Rx.

5 Feb 2015

RXi closes exclusive global license agreement with Hapten Pharmaceuticals for Samcyprone

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering and developing innovative therapies addressing high-unmet medical needs, today announced the closing of its previously disclosed exclusive global license agreement for the therapeutic use of Samcyprone with Hapten Pharmaceuticals, LLC.

5 Feb 2015

Study: 45% of RTI patients inappropriately prescribed antibiotics in outpatient settings

A new study found 45 percent of patients with respiratory tract infections (RTIs) were inappropriately prescribed antibiotics in an outpatient practice of general internal medicine and family medicine.

5 Feb 2015

Providing knowledge about contraception can significantly improve use of isotretinoin

Providing women who take a powerful acne drug with a fact sheet about contraception while visiting the dermatologist can significantly improve their awareness of the most effective birth control options and may prevent unintended pregnancies and birth defects that can be caused by the drug, according to a University of Pittsburgh School of Medicine study published Feb. 4 in the journal JAMA Dermatology.

5 Feb 2015

Retigabine drug could reduce debilitating impact of strokes

New research suggests that an already-approved drug could dramatically reduce the debilitating impact of strokes, which affect nearly a million Americans every year.

5 Feb 2015

Antibodies used in research lab should be made by recombinant DNA technology, say authors

Antibodies are now established as therapeutics and indispensable in the research lab. In con-trast to high-quality therapeutics, commercial antibodies used in research often do not proper-ly function, as an international group of authors around Andreas Plückthun of UZH have warned.

5 Feb 2015

Diplomat to dispense FDA-approved IBRANCE (palbociclib) to treat metastatic breast cancer

Diplomat Pharmacy, Inc., the nation's largest independent specialty pharmacy, announced today it will dispense Pfizer's new breakthrough medication, IBRANCE (palbociclib), starting tomorrow, Feb. 5.

4 Feb 2015

Epidemiologist urges people to get vaccinated against measles

Americans may be victims of their own success when it comes to the eradication of infectious diseases and take their disease-free lives for granted, says Jorge Parada, MD, hospital epidemiologist and medical director of the Infection Prevention and Control program at Loyola University Health System.

4 Feb 2015

Researchers suggest novel concept for developing vaccines against HIV and cancer

A experimental trial has shown successful by inducing serum in mice and has been highly neutralizing towards those ailments.

4 Feb 2015

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

A new molecule has been found that protects the heart from toxic breast cancer drugs and also kills the cancerous tumour. The research from Italy addresses the burgeoning problem of heart disease in cancer survivors and is announced by the European Society of Cardiology today on World Cancer Day.

4 Feb 2015

Pharmaceutical News

Breakthrough therapies for blood cancers may provide reasonable value for money spent

Breakthrough blood cancer therapies may provide reasonable value for money spent

MIT engineers discover way to grow liver-like cells to test potential malaria drugs

New report explores measures to address shortages of lifesaving medicines

G1 Therapeutics receives $33 million in Series B funding to develop effective treatments for cancer

Isis receives $10 million from Biogen Idec to begin IND-supporting studies of ISIS-BIIB4 Rx

RXi closes exclusive global license agreement with Hapten Pharmaceuticals for Samcyprone

Study: 45% of RTI patients inappropriately prescribed antibiotics in outpatient settings

Providing knowledge about contraception can significantly improve use of isotretinoin

Retigabine drug could reduce debilitating impact of strokes

Antibodies used in research lab should be made by recombinant DNA technology, say authors

Diplomat to dispense FDA-approved IBRANCE (palbociclib) to treat metastatic breast cancer

Epidemiologist urges people to get vaccinated against measles

Researchers suggest novel concept for developing vaccines against HIV and cancer

Research: New molecule safeguards heart from toxic breast cancer drugs, kills cancerous tumour

New drug gets FDA approval for treatment of women with advanced breast cancer

Merck announces US availability of BELSOMRA (suvorexant) for treatment of insomnia

ESMO highlights collaborative efforts to improve access to cancer medicines

Cphi partners with InformEx to launch new InformEx cGMP Zone at 2015 show

New Johns Hopkins research suggests that vitamin A may protect children against malaria

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News